These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23663196)

  • 1. Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism.
    Baizabal-Carvallo JF; Jankovic J
    Neuromodulation; 2014 Jan; 17(1):104-6. PubMed ID: 23663196
    [No Abstract]   [Full Text] [Related]  

  • 2. Variable frequency stimulation of subthalamic nucleus for freezing of gait in Parkinson's disease.
    Jia F; Guo Y; Wan S; Chen H; Hao H; Zhang J; Li L
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1471-2. PubMed ID: 26467485
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subthalamic stimulation or subthalamic lesion for Parkinson's disease? A case report.
    Anheim M; Dowsey-Limousin P; Krack P; Chabardès S; Benabid AL; Pollak P
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1485-7. PubMed ID: 26531847
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of secondary unresponsiveness to dopaminergic drugs with preserved response to subthalamic nucleus stimulation in Parkinson's disease.
    Lenka A; Jhunjhunwala KR; Stezin A; Manjunath M; Srinivas D; Yadav R; Pal PK
    Neurol India; 2018; 66(Supplement):S135-S137. PubMed ID: 29503336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease.
    Navailles S; Benazzouz A; Bioulac B; Gross C; De Deurwaerdère P
    J Neurosci; 2010 Feb; 30(6):2356-64. PubMed ID: 20147561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism.
    Krack P; Dowsey PL; Benabid AL; Acarin N; Benazzouz A; Künig G; Leenders KL; Obeso JA; Pollak P
    Neurology; 2000 Jun; 54(11):2182-4. PubMed ID: 10851392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor improvement with bilateral subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive secondary parkinsonism.
    Kotagal V; Patil PG; Chou KL
    Parkinsonism Relat Disord; 2012 Jan; 18(1):79-81. PubMed ID: 21903443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's goal: ease symptoms, slow progression.
    Johns Hopkins Med Lett Health After 50; 2006 Jun; 18(4):4-5. PubMed ID: 16795901
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
    Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
    Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease.
    Arai E; Arai M; Uchiyama T; Higuchi Y; Aoyagi K; Yamanaka Y; Yamamoto T; Nagano O; Shiina A; Maruoka D; Matsumura T; Nakagawa T; Katsuno T; Imazeki F; Saeki N; Kuwabara S; Yokosuka O
    Brain; 2012 May; 135(Pt 5):1478-85. PubMed ID: 22522940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of deep brain stimulation on postencephalitic parkinsonism: a case report.
    Hu SC; Hebb AO
    Mov Disord; 2012 Jul; 27(8):1071-2. PubMed ID: 22555963
    [No Abstract]   [Full Text] [Related]  

  • 15. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Lanotte M; Lopiano L
    Mov Disord; 2011 Mar; 26(4):664-70. PubMed ID: 21469197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
    Collins-Praino LE; Paul NE; Ledgard F; Podurgiel SJ; Kovner R; Baqi Y; Müller CE; Senatus PB; Salamone JD
    Eur J Neurosci; 2013 Jul; 38(1):2183-91. PubMed ID: 23600953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts.
    Hamel W; Fietzek U; Morsnowski A; Schrader B; Herzog J; Weinert D; Pfister G; Müller D; Volkmann J; Deuschl G; Mehdorn HM
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1036-46. PubMed ID: 12876231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.